INSPIRE MEDICAL SYSTEM ($INSP) posted quarterly earnings results for Q1 2026 on Monday, May 4th. The company reported earnings of $0.10 per share, beating estimates of -$0.28 by $0.38. The company also reported revenue of $204,580,000, missing estimates of $205,989,612 by $-1,409,612.
Stock price change since market close: -16.06%
You can see Quiver Quantitative's $INSP stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
INSPIRE MEDICAL SYSTEM Insider Trading Activity
INSPIRE MEDICAL SYSTEM insiders have traded $INSP stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $INSP stock by insiders over the last 6 months:
- SHAWN MCCORMICK has made 0 purchases and 2 sales selling 3,200 shares for an estimated $421,760.
- JOHN RONDONI (See Remarks) sold 109 shares for an estimated $10,900
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
INSPIRE MEDICAL SYSTEM Hedge Fund Activity
We have seen 182 institutional investors add shares of INSPIRE MEDICAL SYSTEM stock to their portfolio, and 206 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 2,871,080 shares (-86.1%) from their portfolio in Q4 2025, for an estimated $264,799,708
- WELLINGTON MANAGEMENT GROUP LLP added 2,211,091 shares (+inf%) to their portfolio in Q4 2025, for an estimated $203,928,922
- CITADEL ADVISORS LLC removed 1,237,091 shares (-70.8%) from their portfolio in Q4 2025, for an estimated $114,096,902
- BAILLIE GIFFORD & CO removed 1,084,350 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $100,009,600
- M&T BANK CORP added 931,049 shares (+inf%) to their portfolio in Q4 2025, for an estimated $85,870,649
- D. E. SHAW & CO., INC. added 853,305 shares (+237.8%) to their portfolio in Q4 2025, for an estimated $78,700,320
- MORGAN STANLEY added 809,121 shares (+179.5%) to their portfolio in Q4 2025, for an estimated $74,625,229
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
INSPIRE MEDICAL SYSTEM Government Contracts
We have seen $3,608,717 of award payments to $INSP over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- IMPLANTS: $142,010
- INSPIRE IMPLANTABLE PULSE GENERATOR V LEAD SLEEP REMOTE: $50,150
- SURGICAL IMPLANT: $50,150
- PROSTHETIC ORDER - IMPLANT ITEMS: $49,900
- IMPLANT FOR A VETERAN.: $47,336
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
INSPIRE MEDICAL SYSTEM Analyst Ratings
Wall Street analysts have issued reports on $INSP in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Mizuho issued a "Outperform" rating on 02/12/2026
- RBC Capital issued a "Outperform" rating on 12/17/2025
- Stifel issued a "Buy" rating on 11/24/2025
To track analyst ratings and price targets for INSPIRE MEDICAL SYSTEM, check out Quiver Quantitative's $INSP forecast page.
INSPIRE MEDICAL SYSTEM Price Targets
Multiple analysts have issued price targets for $INSP recently. We have seen 14 analysts offer price targets for $INSP in the last 6 months, with a median target of $72.0.
Here are some recent targets:
- Richard Newitter from Truist Securities set a target price of $64.0 on 04/15/2026
- Anthony Petrone from Mizuho set a target price of $70.0 on 04/13/2026
- Jonathan Block from Stifel set a target price of $70.0 on 04/10/2026
- Daniel Markowitz from Evercore ISI Group set a target price of $62.0 on 04/06/2026
- Mike Polark from Baird set a target price of $74.0 on 02/12/2026
- Larry Biegelsen from Wells Fargo set a target price of $70.0 on 02/12/2026
- Adam Maeder from Piper Sandler set a target price of $85.0 on 02/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
